Dexamedomedine: will receive bupivacaine 0.25% (3ml) + dexmedetomidine (1 mic/kg), total volume 5ml by adding normal saline.
Dexamethasone: will receive bupivacaine 0.25% (3ml) + dexamethasone (4mg), total volume 5ml by adding normal saline
Bubpivacaine: will receive bupivacaine 0.25% (3ml) + normal saline, total volume (5 ml).
Study summary
This study will test the effect of adding dexamethasone versus dexmedetomidine as adjuvants to bupivacaine in sphenopalatine ganglion block used for pain after rhinoplasty
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
1. Age 18-65 years.
2. Sex: of either sex.
3. American Society of Anaesthesiologists (ASA) Physical Status Class I and II.
4. BMI \< 35
5. Scheduled for rhinoplasty surgeries under general anaesthesia.
Exclusion Criteria:
1. Declining to give written informed consent.
2. History of allergy to the medications used in the study.
3. Contraindications to regional anesthesia (including patient refusal, coagulopathy and local infection).
4. Psychiatric disorder.
Primary outcome measure(s)
The time to the first request of analgesia — 9 months The time interval between the onset of the local infiltration done at the end of the operation and the first request to postoperative analgesia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.